» Articles » PMID: 27831827

Mitotic Entry: The Interplay Between Cdk1, Plk1 and Bora

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2016 Nov 11
PMID 27831827
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Polo-like kinase 1 (Plk1) is an important mitotic kinase that is crucial for entry into mitosis after recovery from DNA damage-induced cell cycle arrest. Plk1 activation is promoted by the conserved protein Bora (SPAT-1 in C. elegans), which stimulates the phosphorylation of a conserved residue in the activation loop by the Aurora A kinase. In a recent article published in Cell Reports, we show that the master mitotic kinase Cdk1 contributes to Plk1 activation through SPAT-1/Bora phosphorylation. We identified 3 conserved Sp/Tp residues that are located in the N-terminal, most conserved part, of SPAT-1/Bora. Phosphorylation of these sites by Cdk1 is essential for Plk1 function in mitotic entry in C. elegans embryos and during DNA damage checkpoint recovery in mammalian cells. Here, using an untargeted Förster Resonance Energy Transfer (FRET) biosensor to monitor Plk1 activation, we provide additional experimental evidence supporting the importance of these phosphorylation sites for Plk1 activation and subsequent mitotic entry after DNA damage. We also briefly discuss the mechanism of Plk1 activation and the potential role of Bora phosphorylation by Cdk1 in this process. As Plk1 is overexpressed in cancer cells and this correlates with poor prognosis, understanding how Bora contributes to Plk1 activation is paramount for the development of innovative therapeutical approaches.

Citing Articles

Construction and high-throughput screening of gradient nanowire coatings on titanium surface towards ameliorated osseointegration.

Hang R, Zhao Y, Chen H, Li X, Yao R, Sun Y Mater Today Bio. 2025; 30:101392.

PMID: 39759850 PMC: 11697249. DOI: 10.1016/j.mtbio.2024.101392.


Only Infant -Rearranged Leukemia Is Susceptible to an Inhibition of Polo-like Kinase 1 (PLK-1) by Volasertib.

Fischer J, Erkner E, Radszuweit P, Hentrich T, Keppeler H, Korkmaz F Int J Mol Sci. 2024; 25(23).

PMID: 39684470 PMC: 11641557. DOI: 10.3390/ijms252312760.


CDC6 as a Key Inhibitory Regulator of CDK1 Activation Dynamics and the Timing of Mitotic Entry and Progression.

El Dika M, Dudka D, Kloc M, Kubiak J Biology (Basel). 2023; 12(6).

PMID: 37372141 PMC: 10295169. DOI: 10.3390/biology12060855.


UBAP2L-dependent coupling of PLK1 localization and stability during mitosis.

Guerber L, Vuidel A, Liao Y, Kleiss C, Grandgirard E, Sumara I EMBO Rep. 2023; 24(6):e56241.

PMID: 37039032 PMC: 10240199. DOI: 10.15252/embr.202256241.


Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia.

Kim J, Park E, Shin M, Park S Microbiol Spectr. 2023; :e0491922.

PMID: 36877015 PMC: 10100927. DOI: 10.1128/spectrum.04919-22.


References
1.
Xu J, Shen C, Wang T, Quan J . Structural basis for the inhibition of Polo-like kinase 1. Nat Struct Mol Biol. 2013; 20(9):1047-53. DOI: 10.1038/nsmb.2623. View

2.
Sahoo H, Schwille P . FRET and FCS--friends or foes?. Chemphyschem. 2011; 12(3):532-41. DOI: 10.1002/cphc.201000776. View

3.
Thomas Y, Cirillo L, Panbianco C, Martino L, Tavernier N, Schwager F . Cdk1 Phosphorylates SPAT-1/Bora to Promote Plk1 Activation in C. elegans and Human Cells. Cell Rep. 2016; 15(3):510-518. DOI: 10.1016/j.celrep.2016.03.049. View

4.
McGowan C, Russell P . Human Wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr15. EMBO J. 1993; 12(1):75-85. PMC: 413177. DOI: 10.1002/j.1460-2075.1993.tb05633.x. View

5.
Mueller P, Coleman T, Kumagai A, Dunphy W . Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science. 1995; 270(5233):86-90. DOI: 10.1126/science.270.5233.86. View